0000000001140036

AUTHOR

Susanne Knapp

showing 1 related works from this author

Autoregulatory role of interleukin-10 in hepatitis C patients treated with IFN-alpha.

2004

Interferon-alpha2 (IFN-alpha2) is used as standard treatment of patients with chronic hepatitis C (cHCV), but little is known about the immunomodulatory effects of this cytokine in vivo. We have studied immunologic parameters in freshly isolated peripheral blood mononuclear cells (PBMC) of 26 patients with cHCV 12 h before and 12 h after the first s.c. injection of 5-6 MU IFN-alpha2. In PBMC obtained after IFN injection, a substantial increase in IL-10 production after antigen-specific and nonspecific stimulation was observed, whereas IFN-gamma production and proliferation were significantly diminished compared with PBMC obtained before IFN injection. Patients were stratified according to s…

AdultMaleGenotypeHepacivirusmedicine.medical_treatmentImmunologyStimulationHepacivirusIn Vitro TechniquesInterferon alpha-2Peripheral blood mononuclear cellPolymorphism Single NucleotideInterferon-gammaIn vivoVirologyMedicineHomeostasisHumansInterferon gammaPromoter Regions GeneticAgedbiologyBase Sequencebusiness.industryInterferon-alphaCell BiologyHepatitis CDNAHepatitis C ChronicMiddle Agedmedicine.diseasebiology.organism_classificationRecombinant ProteinsInterleukin-10Interleukin 10CytokineImmunologyLeukocytes MononuclearFemalebusinessmedicine.drugJournal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research
researchProduct